Oxford Asset Management’s NeoGenomics NEO Stock Holding History

Oxford Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-31,383	Closed	-$600K	–	1975
2019 Q3	$600K	Sell	31,383 -79,386	-72%	-$1.86M	0.01%	1186
2019 Q2	$2.43M	Sell	110,769 -13,867	-11%	-$304K	0.05%	561
2019 Q1	$2.55M	Sell	124,636 -103,218	-45%	-$1.79M	0.06%	461
2018 Q4	$2.87M	Buy	227,854 +128,904	+130%	+$1.92M	0.07%	310
2018 Q3	$1.52M	Sell	98,950 -58,468	-37%	-$808K	0.03%	812
2018 Q2	$2.08M	Buy	+157,418	New	+$1.73M	0.04%	641
2016 Q1	–	Sell	-144,955	Closed	-$1.17M	–	857
2015 Q4	$1.17M	Buy	+144,955	New	+$1.06M	0.03%	499

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Oxford Asset Management's NEO Position: Q4 2019 in Review

Oxford Asset Management sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 31,383 shares — an estimated $600K sold.

Oxford Asset Management first reported a position in NEO in Q4 2015 and held it in 7 quarters. The position peaked at $2.87M in Q4 2018. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

Oxford Asset Management reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 31,383 NeoGenomics shares in Q4 2019, an estimated $600K.
Oxford Asset Management first reported a position in NeoGenomics in Q4 2015 and held it in 7 quarters.
Oxford Asset Management's NeoGenomics position peaked at $2.87M in Q4 2018.
261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.